Cargando…

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

BACKGROUND: Gefitinib is frequently used to treat patients with non-small cell lung cancer (NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2. ABCG2 gene polymorphisms have been suggested to be associated with ABCG2 protein expression and function and may influence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Lina, Zhang, Chunling, He, Hairong, Pan, Zhenyu, Fan, Di, He, Yinli, You, Haisheng, Li, Yuanjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798561/ https://www.ncbi.nlm.nih.gov/pubmed/29440914 http://dx.doi.org/10.2147/OTT.S154244

Ejemplares similares

GENETIC POLYMORPHISMS OF THE ADENOSINE TRIPHOSPHATE-BINDING CASSETTE TRANSPORTERS(ABCG2, ABCB1) AND GEFITINIB TOXICITY
por: TAMURA, MARIKO, et al.
Publicado: (2012)

Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis
por: Pan, Zhenyu, et al.
Publicado: (2017)

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
por: Galetti, Maricla, et al.
Publicado: (2015)

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway
por: Huang, Yutang, et al.
Publicado: (2020)

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis
por: Yi, Min, et al.
Publicado: (2023)

Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma
por: Sun, Fengjun, et al.
Publicado: (2021)

The Efficacy and Toxicity of Gefitinib in Treating Non-small Cell Lung Cancer: A Meta-analysis of 19 Randomized Clinical Trials
por: Wo, Hongmei, et al.
Publicado: (2018)

A meta-analysis of ABCG2 gene polymorphism and non-small cell lung cancer outcomes
por: Fu, Lei, et al.
Publicado: (2020)

Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells
por: Chen, Yun-Ju, et al.
Publicado: (2011)

Picky ABCG5/G8 and promiscuous ABCG2 ‐ a tale of fatty diets and drug toxicity
por: Khunweeraphong, Narakorn, et al.
Publicado: (2020)

Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib
por: Lemos, C, et al.
Publicado: (2009)

Impact of ABCG2 Gene Polymorphism on the Predisposition to Psoriasis
por: Huang, Yu-Huei, et al.
Publicado: (2021)

Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Hong, Dongsheng, et al.
Publicado: (2016)

Gefitinib in Non Small Cell Lung Cancer
por: Costanzo, Raffaele, et al.
Publicado: (2011)

Cellular photo(geno)toxicity of gefitinib after biotransformation
por: El Ouardi, Meryem, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China
por: Shu, Yamin, et al.
Publicado: (2021)

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients
por: Chen, Xueqin, et al.
Publicado: (2015)

Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum
Publicado: (2016)

ABCG2 Polymorphisms and Predictive Fluoroquinolone Phototoxicity in Nondomestic Felids
por: Gochenauer, Alexandria E., et al.
Publicado: (2022)

Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms' tumor
por: Pan, Zhenyu, et al.
Publicado: (2019)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis
por: Dalle Fratte, Chiara, et al.
Publicado: (2023)

Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity
por: Tan, Yinli, et al.
Publicado: (2023)

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
por: Chen, Siying, et al.
Publicado: (2018)

Relative roles of ABCG5/ABCG8 in liver and intestine
por: Wang, Jin, et al.
Publicado: (2015)

Functional Cooperativity between ABCG4 and ABCG1 Isoforms
por: Hegyi, Zoltán, et al.
Publicado: (2016)

ABCG5 and ABCG8 Are Involved in Vitamin K Transport
por: Matsuo, Michinori, et al.
Publicado: (2023)

The ABCG2 Polymorphism rs2725220 Is Associated with Hyperuricemia in the Korean Population
por: Sull, Jae Woong, et al.
Publicado: (2014)

ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches
por: Cleophas, MC, et al.
Publicado: (2017)

The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature
por: Chen, Pin, et al.
Publicado: (2012)

BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells
por: Yu, Yaya, et al.
Publicado: (2023)

Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer
por: Horiike, A, et al.
Publicado: (2011)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
por: Li, Meng-Jiao, et al.
Publicado: (2016)

Sitosterolemia: Twenty Years of Discovery of the Function of ABCG5 ABCG8
por: Williams, Kori, et al.
Publicado: (2021)

Gefitinib versus Docetaxel in Treated Non-small-cell Lung Cancer: A Meta-analysis
por: Wang, Bing, et al.
Publicado: (2017)

The influence of ABCG2 polymorphism on erlotinib efflux in the K562 cell line
por: Svedberg, Anna, et al.
Publicado: (2020)

Overexpression of CTEN is associated with gefitinib resistance in non-small cell lung cancer
por: Lu, Xiangdong, et al.
Publicado: (2021)

The impact of the lymph node density on overall survival in patients with Wilms’ tumor: a SEER analysis
por: You, Haisheng, et al.
Publicado: (2018)

Functional relationship of AtABCG21 and AtABCG22 in stomatal regulation
por: Kuromori, Takashi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0jtmfgrekunkbq7khpmd3nbobk